Search results
Bristol-Myers Gets FDA Acceptance of Review for Subcutaneous Opdivo Formulation
Market Watch· 4 days agoBristol Myers Squibb on Monday said the Food and Drug Administration has accepted its application seeking approval of an subcutaneous formulation of its blockbuster cancer drug Opdivo ...
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
WFRV 5 Green Bay· 15 hours agoUSA News Group – In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden's "Cancer ...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript May 7, 2024...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Finance· 2 days agoQ: What are the expectations for the subcutaneous versions of Tecentriq and Opdivo in terms of covering IV indications? A: Helen Torley clarified that while Tecentriq subcutaneous ...
Mesothelioma
Health· 7 days agoImmunotherapy A relatively newer approach, immunotherapy involves taking specific medications that trigger the immune system to attack cancer cells. For...
Earnings call: Halozyme maintains positive outlook amid strong Q1 performance By Investing.com
Investing.com· 2 days agoHalozyme Therapeutics Inc. (NASDAQ:HALO) has reported a robust start to 2024, with first-quarter...
Fisher Asset Management LLC Acquires 127,228 Shares of Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 3 days agoFisher Asset Management LLC increased its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 130.7% in the 4th quarter, according to the company in its most recent filing with the ...
Nexavar Dosage: Form, Strength, How to Take, and More
Healthline· 4 days agoNexavar (sorafenib) is a prescription drug used to treat liver, kidney, and thyroid cancers. Nexavar belongs to a group of drugs called kinase inhibitors and contains the active ingredient sorafenib ...
Samsung Biologics poised for growth pending BIOSECURE bill approval in US
BioPharma-Reporter· 3 days agoThe bill, introduced in the House of Representatives in January 2024, aims to restrict federal...
